Metalloproteinases are involved in a variety of diseases, particularly those characterized by excessive ECM breakdown. Their dysregulation is linked to cancer progression, cardiovascular diseases, and chronic inflammatory conditions like arthritis. In cancer, for instance, metalloproteinases facilitate tumor invasion and metastasis by breaking down ECM barriers.
